Immunofluorescence (IF) and Immunohistochemistry (IHC) results revealed that, in Neo‐CRCVAS‐treated mice, lymphocytes were recruited to the tumor site, but the infiltration of lymphocytes into the tumor tissue and the secretion of IFN‐γ remained limited (Figure 2D). The gene discussed is IFNG; the disease is neoplasm.